Dr. Yujia Sun focuses her work on patent drafting, assisting prosecution before the United States Patent and Trademark Office, and coordination of patent prosecution in other jurisdictions in association with foreign patent counsel. She also has experience in IP due diligence inquiries, including freedom-to-operate and patentability analyses, with an emphasis on biotechnology and pharmaceuticals.
Dr. Sun has worked with a wide range of clients, including startup biotech companies, large pharmaceutical companies, universities, independent inventors, and venture capitalists. She has worked with clients in a number of areas, including cancer immunotherapy, antibodies, gene therapy, pharmaceuticals, next-generation sequencing, and diagnostics.
Prior to joining Morrison & Foerster, Dr. Sun worked as a Biotechnology Intern at the Office of Industrial Liaison of New York University, where she helped develop the business plan for a startup to be formed around a pharmacotherapy device invented by NYU faculty. Her role included researching the relevant technology, analyzing the market potential and competitive landscape, and designing strategies for technological improvement and securing regulatory approval requirements.
Dr. Sun received her Ph.D. (dissertation pass with distinction) and M.S. in biology from New York University, where she studied transcriptional regulation and pattern formation in early embryos and concentrated on developmental genetics, epigenetics, genomics, next-generation sequencing techniques, molecular biology, and confocal microscopy. She received her B.S. in biological sciences from Tsinghua University in China.
Dr. Sun is fluent in English and Mandarin.
©1996-2019 Morrison & Foerster LLP. All rights reserved.